CME(CME)
CME
Q4 2026 EPS Estimate
$2.96
Oct 28, 2026 · Reports before open
Revenue Estimate
$1.70B
FY2026E EPS$12.25
FY2027E EPS$12.92
Analyst Sentiment
Wall St. Consensus
Hold22 analysts·High coverage
59
Score
12 Buy (55%)6 Hold (27%)4 Sell (18%)
Rating Breakdown
Strong Buy
00%
Buy
1255%
Hold
627%
Sell
418%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$260.00
-3.6%
Consensus
$316.00
+17.1%
Bull
$330.00
+22.3%
12-Month Target Range22 analysts
$260.00$316.00$330.00
Current $269.80Consensus
Current Price
$269.80
Upside to Consensus
$46.20
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+5.04%
EPS+5.41%
FY2028
Rev+6.48%
EPS+7.34%
FY2029
Rev+7.60%
EPS+8.14%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $7.03B | $7.38B | $7.86B | $8.46B | $8.73B |
| Low | $6.98B | $7.03B | $7.41B | $8.14B | $8.40B |
| High | $7.16B | $7.59B | $8.21B | $8.76B | $9.04B |
| EBITDA Avg | $6.42B | $6.74B | $7.18B | $7.72B | $7.97B |
| Low | $6.37B | $6.42B | $6.76B | $7.43B | $7.67B |
| High | $6.53B | $6.93B | $7.49B | $7.99B | $8.25B |
| EBIT Avg | $6.31B | $6.63B | $7.05B | $7.59B | $7.83B |
| Low | $6.26B | $6.31B | $6.65B | $7.31B | $7.54B |
| High | $6.42B | $6.81B | $7.36B | $7.86B | $8.11B |
| Net Income Avg | $4.43B | $4.62B | $4.92B | $5.40B | $5.78B |
| Low | $4.35B | $4.39B | $4.76B | $5.14B | $5.50B |
| High | $4.54B | $4.81B | $5.14B | $5.65B | $6.05B |
| EPS Avg | $12.25 | $12.92 | $13.86 | $14.99 | $16.05 |
| Low | $12.07 | $12.18 | $13.20 | $14.26 | $15.27 |
| High | $12.60 | $13.34 | $14.27 | $15.68 | $16.79 |
| Analysts (Rev / EPS) | 11 / 10 | 11 / 10 | 7 / 4 | 3 / 1 | 5 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $1.70B | $1.75B | $1.85B | $1.83B | $1.82B | $1.89B | $2.04B | $1.94B |
| Low | $1.69B | $1.70B | $1.79B | $1.77B | $1.77B | $1.83B | $1.97B | $1.88B |
| High | $1.72B | $1.79B | $1.93B | $1.91B | $1.90B | $1.97B | $2.13B | $2.03B |
| EBITDA Avg | $1.55B | $1.59B | $1.69B | $1.67B | $1.66B | $1.73B | $1.86B | $1.77B |
| Low | $1.54B | $1.56B | $1.63B | $1.62B | $1.61B | $1.67B | $1.80B | $1.72B |
| High | $1.57B | $1.63B | $1.76B | $1.74B | $1.74B | $1.80B | $1.94B | $1.85B |
| EBIT Avg | $1.52B | $1.57B | $1.66B | $1.64B | $1.64B | $1.70B | $1.83B | $1.74B |
| Low | $1.51B | $1.53B | $1.61B | $1.59B | $1.58B | $1.64B | $1.77B | $1.69B |
| High | $1.54B | $1.60B | $1.73B | $1.71B | $1.71B | $1.77B | $1.91B | $1.82B |
| Net Income Avg | $1.07B | $1.08B | $1.19B | $1.17B | $1.16B | $1.18B | $1.36B | $1.27B |
| Low | $1.02B | $1.05B | $1.14B | $1.12B | $1.12B | $1.13B | $1.30B | $1.22B |
| High | $1.13B | $1.11B | $1.26B | $1.24B | $1.23B | $1.25B | $1.44B | $1.34B |
| EPS Avg | $2.94 | $2.97 | $3.29 | $3.23 | $3.21 | $3.26 | $3.75 | $3.51 |
| Low | $2.82 | $2.89 | $3.15 | $3.09 | $3.08 | $3.13 | $3.59 | $3.36 |
| High | $3.13 | $3.05 | $3.47 | $3.41 | $3.39 | $3.45 | $3.96 | $3.71 |
| Analysts (Rev / EPS) | 7 / 10 | 7 / 10 | 3 / 8 | 3 / 8 | 3 / 8 | 6 / 8 | 5 / 9 | 4 / 9 |